Iratumumab

Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL).
Read more
€0.00 (tax incl.)
Reference:
HY-P99669
Product Details
HY-P99669

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
CAS
640735-09-7

Menu

Settings